Abstract
Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Current Pediatric Reviews
Title: Neuroprotection for Ischemic Injury in the Immature Brain
Volume: 1 Issue: 2
Author(s): Anne M. Comi
Affiliation:
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Abstract: Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Export Options
About this article
Cite this article as:
Comi M. Anne, Neuroprotection for Ischemic Injury in the Immature Brain, Current Pediatric Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573396054065448
DOI https://dx.doi.org/10.2174/1573396054065448 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Recombinant Tissue-Type Plasminogen Activator (Alteplase) in the Management of Acute Ischemic Stroke: A Review of its Pharmacological Properties, Efficacy, Safety and Pharmacoeconomic Aspects
Current Drug Therapy Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Current Medicinal Chemistry - Central Nervous System Agents Targeted Drug Delivery: Trends and Perspectives
Current Drug Delivery Cerebral Hemorrhage Produced by Thrombolytic and Anti-Thrombotic Agents: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents CD44 and its Role in Inflammation and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) DNA Damage and Repair in the Brain After Cerebral Ischemia
Current Topics in Medicinal Chemistry Competitive Gly/NMDA Receptor Antagonists
Current Topics in Medicinal Chemistry Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Current Alzheimer Research Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Optical Sensors for Detection of Amino Acids
Current Medicinal Chemistry Neutralizing Endogenous VEGF Following Traumatic Spinal Cord Injury Modulates Microvascular Plasticity but not Tissue Sparing or Functional Recovery
Current Neurovascular Research Aquaporins and Neurodegenerative Diseases
Current Neuropharmacology New Frontiers in the Therapeutic Management of Transplant Rejection
Current Pharmaceutical Design Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics
Current Neuropharmacology Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Current Cancer Drug Targets The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Current Drug Targets The Impact of Excessive Alcohol Use on Prospective Memory: A Brief Review
Current Drug Abuse Reviews